Real-World Treatment Patterns of Nivolumab + Cabozantinib Compared with Other 1L IO Combinations in mRCC
Interview: Cherrishe Brown-Bickerstaff, PhD, MPH, Senior Observational Researcher at Ontada, discusses the clinical impact of nivolumab + cabozantinib in metastatic renal cell carcinoma.